-
-
-
-
-
-
-
Aerie Pharmaceuticals Announces Positive Topline Results of Netarsudil Ophthalmic Solution in Pilot Phase 2 Study Supporting Clinical Development in Japan
-
-
-
-
-
-
-
Aerie Pharmaceuticals, Inc. Announces Drug Application for Regulatory Approval Accepted for Review in Europe
-
-
-
-
-
-
-
Aerie Pharmaceuticals Announces Appointment of Thomas A. Shepard as Vice President, Implant Manufacturing
-
-
-
-
-
-
-
Aerie Pharmaceuticals, Inc. and DSM Biomedical, Inc. Expand Collaboration Agreement Focused on Novel Drug Delivery Technology in Ophthalmology
-
-
-
-
-
-
-
Aerie Pharmaceuticals Announces Appointment of Paul Bae as Vice President of Human Resources
-
-
-
-
-
-
-
Aerie Pharmaceuticals to Announce Third Quarter 2017 Financial Results and Host Conference Call on Wednesday, November 8, 2017
-
-
-
-
-
-
-
Aerie Pharma (AERI) to Acquire Rights for PRINT Technology in Ophthalmology from Envisia Therapeutics
-
14,982 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

